Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03557749 · ClinicalTrials.gov registry record
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Terminated
- Registry status
- 210
- Enrollment target
NCT03557749 is a clinical trial that was terminated before completion, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 210 participants.
The verdict
NCT03557749 was terminated before completion, sponsored by Masonic Cancer Center, University of Minnesota.
- TERMINATED
- Registry status
- 210 participants
- Enrollment target
Study Summary
This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbiota, and their interactions. Fluid (including but not limited to, blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in, processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC) Translational Therapy Lab (TTL).
Interventions
- DIAGNOSTIC_TEST Stool Sample
- DIAGNOSTIC_TEST Blood Sample
- DIAGNOSTIC_TEST Urine Sample
- DIAGNOSTIC_TEST Bronchoalveolar Lavage (BAL) fluid
- DIAGNOSTIC_TEST Gastrointestinal biopsy x 2-4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2018-09-21 |
| Est. Completion | 2023-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03557749
The ClinicalTrials.gov registry entry for NCT03557749 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Stool Sample is the first listed.
NCT03557749 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03557749 about?
NCT03557749 is a clinical study titled "Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies". This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbio...
What is the current status of trial NCT03557749?
This trial is currently terminated. The enrollment target is 210 participants. The study started on 2018-09-21. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT03557749?
The interventions under investigation include: Stool Sample (DIAGNOSTIC_TEST), Blood Sample (DIAGNOSTIC_TEST), Urine Sample (DIAGNOSTIC_TEST), Bronchoalveolar Lavage (BAL) fluid (DIAGNOSTIC_TEST), Gastrointestinal biopsy x 2-4 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03557749?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.